Current Ratio

The current ratio of 7.10x means Catalyst Pharmaceuticals has $7.10 in current assets—cash, receivables, inventory—for every $1 of short-term debt due within a year, indicating a very strong ability to pay near-term obligations.

This ratio is more than three times the healthcare sector median of 2.10x, placing the company in the 90th percentile among its peers, meaning it holds more liquidity than 90% of similar firms. Trend data is unavailable: the year-over-year and quarter-over-quarter changes are both listed as N/A, and no historical values beyond the current figure are provided. With such a high current ratio but no trend to confirm direction, the metric signals a low immediate default risk but may also suggest idle cash or inefficient asset use—a neutral factor for risk assessment. The NEUTRAL verdict is supported by this metric: the extreme liquidity buffers against downside risk, but without trend context or offsetting growth indicators, it does not justify an upbeat or cautious tilt.

Frequently Asked Questions

Closest Sector Peers